ArriVent BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	49.87	74.29	150.39	163.37	37.28
Short-Term Investments	126.21	144.57	-	-	-
Cash & Short-Term Investments	176.08	218.86	150.39	163.37	37.28
Cash Growth	-44.52%	45.53%	-7.95%	338.23%	-
Other Receivables	0.51	0.5	0.76	0.5	0.25
Receivables	0.51	0.5	0.76	0.5	0.25
Prepaid Expenses	1.23	0.41	0.37	0.33	0.03
Other Current Assets	7.98	7.21	8.45	18.42	5.39
Total Current Assets	185.79	226.98	159.97	182.62	42.95
Property, Plant & Equipment	0.12	0.15	0.29	0.14	-
Long-Term Investments	29.41	47.68	-	-	-
Long-Term Deferred Charges	-	-	2.73	-	-
Other Long-Term Assets	0.18	0.13	0.11	0.07	0.09
Total Assets	215.5	274.94	163.1	182.83	43.04
Accounts Payable	4.36	3.78	4.53	3.09	0.29
Accrued Expenses	8.45	13.33	6.95	5.14	1.53
Current Portion of Leases	0.14	0.16	0.14	0.13	-
Total Current Liabilities	12.95	17.27	11.62	8.36	1.82
Long-Term Leases	-	0.01	0.18	0.01	-
Total Liabilities	12.95	17.29	11.8	8.37	1.82
Common Stock	0	0	-	-	-
Additional Paid-In Capital	505.28	496.2	4.65	3.4	2.96
Retained Earnings	-302.72	-238.33	-157.85	-88.51	-51.61
Comprehensive Income & Other	-0.02	-0.21	-	-	-0
Total Common Equity	202.54	257.65	-153.19	-85.11	-48.64
Shareholders' Equity	202.54	257.65	151.3	174.46	41.22
Total Liabilities & Equity	215.5	274.94	163.1	182.83	43.04
Total Debt	0.14	0.18	0.32	0.14	-
Net Cash (Debt)	175.94	218.69	150.07	163.23	37.28
Net Cash Growth	-44.52%	45.72%	-8.06%	337.86%	-
Net Cash Per Share	5.22	6.95	70.10	127.82	52.42
Filing Date Shares Outstanding	34.21	34.02	33.49	31.96	0.71
Total Common Shares Outstanding	34.04	33.71	2.75	2.6	0.71
Working Capital	172.83	209.71	148.34	174.26	41.13
Book Value Per Share	5.95	7.64	-55.80	-32.76	-68.40
Tangible Book Value	202.54	257.65	-153.19	-85.11	-48.64
Tangible Book Value Per Share	5.95	7.64	-55.80	-32.76	-68.40

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q